Work

Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration‐resistant prostate cancer

Year: 2011

Type: article

Study design: Clinical Trial

Source: The Prostate

DOI: 10.1002/pros.21342

Authors: Donald L. Trump, Heather Payne, Kurt Miller, Johann S. de Bono, Joe Stephenson, Howard A. Burris, Faith Nathan, Maria Taboada, Thomas Morris, Andreas Hubner

Institutions: Roswell Park Comprehensive Cancer Center, University College London Hospitals NHS Foundation Trust, Charité – Universitätsmedizin Berlin, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Prisma Health, Sarah Cannon, AstraZeneca (United States), AstraZeneca (United Kingdom)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, University College London Hospitals NHS Foundation Trust, UCLH Biomedical Research Centre

OpenAlex ID: W2091473284

FWCI: 2.176

Cites: 26

Cited by: 23

Related to: 10